Answers are grounded in this paper and cite their sources.
Genomics encompasses the comprehensive evaluation and understanding of an organism’s complete genome sequence. Nanoparticles, including enzyme-like catalysts, have emerged as a valuable tool in biotechnology because they offer durability, cost-effective performance, and stable catalytic properties. Nanoparticles in genomics have opened new prospects for sensing sensitivity and specificity, nucleic acid amplification, and analysis. The vast inventive approach of nanozymes, comprising intensifying biosensor performance to empower real-time genomic diagnostics, overcomes the overpowering hindrances of conventional enzymatic approaches. This review highlights recent advances in integrating nanozymes into genomic workflows, including gene editing, sequencing technologies, and disease biomarker detection. The challenges associated with their biocompatibility, specificity, and integration into complex biological systems were investigated as well. Finally, the review appraised the subsequent perspectives, concentrating on the emergence of nanozymes with multidimensional utility, potential in personalised medicine, and 3their incorporation with modern emerging innovations like Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and artificial intelligence to revolutionise genomic research and clinical diagnostics.
No takes yet. Share an insight, caveat, or question.
Sarma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: